Document:

EX-4.2

 Exhibit 4.2 

DESCRIPTION OF THE REGISTRANT’S COMMON STOCK 

REGISTERED PURSUANT TO SECTION 12 OF THE 

SECURITIES EXCHANGE ACT OF 1934 
 The
common stock of Community Health Systems, Inc. (the “Company”) is registered under Section 12 of the Securities Exchange Act of 1934, as amended. 

The following description of our common stock is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to
the actual terms and provisions contained in our Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), and our Amended and Restated By-laws (the “Bylaws”),
each of which are incorporated by reference as an exhibit to the Annual Report on Form 10-K, of which this Exhibit 4.2 is a part. We encourage you to read our Certificate of Incorporation, our Bylaws and the
applicable provisions of the Delaware General Corporation Law (“DGCL”), for additional information. 
 Authorized Capital 

We are authorized to issue up to 400,000,000 shares of capital stock, of which 300,000,000 may be shares of common stock, par value $0.01 per share, and
100,000,000 may be shares of preferred stock, par value $0.01 per share. All of the outstanding shares of our common stock are fully paid and nonassessable. 

Voting Rights 
 Holders of our common stock are entitled
to one vote for each share on all matters voted on by our stockholders. Holders of our common stock do not have cumulative voting rights in the election of directors. 

Dividends 
 Subject to the preferences or other rights of
any our preferred stock that may be issued from time to time, holders of our common stock are entitled to participate ratably in dividends on our common stock as declared by our board of directors. 

Absence of Other Rights 
 Holders of our common stock do
not have any preemptive right to subscribe for or purchase any of our securities of any class or kind. Holders of our common stock do not have any subscription, redemption or conversion privileges. 

Liquidation Rights 
 Holders of our common stock are
entitled to share ratably in all assets available for distribution to our stockholders in the event of our liquidation or dissolution, subject to distribution of the preferential amount, if any, to be distributed to holders of our preferred stock.

 Listing 
 Our common stock is listed on the New York
Stock Exchange under the symbol “CYH.” 
 Transfer Agent and Registrar 

The transfer agent and registrar for our common stock is American Stock Transfer & Trust Company, LLC. 

Anti-Takeover Effects of Our Certificate of Incorporation and Bylaws and Provisions of the DGCL 

General 
 Certain provisions of our Certificate of
Incorporation and Bylaws may delay or make more difficult acquisitions or changes of control of us that are not approved by our board of directors. These provisions could have the effect of 

 
discouraging third parties from making proposals involving an acquisition or change of control of the Company, although these kinds of proposals, if made, might be considered desirable by a
majority of our stockholders. These provisions may also have the effect of making it more difficult for third parties to cause the replacement of our current management without the concurrence of our board of directors. 

Number of Directors; Removal; Vacancies 
 Our
Certificate of Incorporation provides that the number of our directors will be determined from time to time exclusively by a vote of a majority of the members of our board of directors then in office. Our Certificate of Incorporation also provides
that, subject to the rights of the holders of any series of preferred stock then outstanding, our board of directors has the exclusive right to fill vacancies, including vacancies created by an increase in the number of directors. This provision
could have the effect of discouraging a potential acquiror from attempting to obtain control of us. Our Certificate of Incorporation further provides that, subject to the rights of the holders of any series of preferred stock then
outstanding, any director elected prior to our 2010 annual meeting of stockholders or any director appointed to fill a vacancy of any director elected prior to the 2010 annual meeting of stockholders may be removed from office at any time, but only
for cause, and any other director may be removed from office at any time, with or without cause, in each case at a meeting called for that purpose and only by the affirmative vote of the holders of a majority of the voting power of all of the shares
of our capital stock then entitled to vote in the election of directors. This provision, in conjunction with the provision authorizing our board of directors to fill vacant directorships, could prevent our stockholders from removing certain
incumbent directors without cause and filling the resulting vacancies with their own nominees. 
 Election of Directors 

Our Bylaws provide that a nominee for director shall be elected to our board of directors if the votes cast for such nominee’s election exceed the votes
cast against such nominee’s election; provided, however, that directors shall be elected by a plurality of the votes cast at any meeting of our stockholders for which (i) our Secretary receives a notice that a stockholder has nominated a
person for election to our board of directors in compliance with the advance notice requirements for stockholder nominees set forth in our Bylaws and/or the proxy access requirements for stockholder nominees set forth in Section 15 of Article
II of our Bylaws and (ii) such nomination has not been withdrawn by such stockholder on or before the 10th day before the Company first mails, provides or makes available its notice of meeting for such meeting to our stockholders. Our
Certificate of Incorporation provides that, at each annual meeting of stockholders, all directors shall be elected for terms expiring at the next annual meeting of stockholders and until such director’s successor shall have been elected and
qualified. 
 Special Meetings of Stockholders 

Our Bylaws provide that special meetings of stockholders, for any purpose or purposes, may only be called by our board of directors, the chairman of our board
of directors or our chief executive officer. 
 Advance Notice for Raising Business or Making Nominations at Meetings 

Our Bylaws provide that no business may be transacted at any meeting of stockholders other than business that is properly brought before the meeting in
accordance with our Bylaws. To be properly brought before a meeting of stockholders, any such business must be a proper matter for stockholder action, and must be (i) specified in the Company’s notice of meeting (or any supplement
thereto), (ii) otherwise brought before the annual meeting by, or at the direction of, our board of directors (or any duly authorized committee thereof), or (iii) otherwise properly brought before the annual meeting by a stockholder who has
given to the Company’s Secretary timely written notice, in proper form, of the stockholder’s intention to bring that business before the meeting. Our Bylaws further provide that only persons who are nominated by, or at the direction of,
our board of directors, or who are nominated by (i) a stockholder who has given timely written notice, in proper form, to the Company’s Secretary prior to an annual meeting of stockholders or a special meeting called for the purpose of
electing directors, or (ii) in accordance with the proxy access provisions set forth in the Bylaws are eligible for election as directors of the Company. These provisions could make it more difficult for our stockholders to raise matters
affecting control of the Company, including tender offers, business combinations or the election or removal of directors, for a stockholder vote. 

  
 2 

 Amendments to the Company’s By-laws 

Our Certificate of Incorporation and Bylaws provide that our board of directors and our stockholders (by affirmative vote of the holders of at least a majority
of the voting power of all of issued and outstanding shares of our capital stock entitled to vote thereon) may adopt, amend, alter, rescind or repeal the bylaws of the Company. 

Amendment of the Company’s Certificate of Incorporation 

Any proposal to amend, alter, change or repeal any provision of our Certificate of Incorporation requires approval by the affirmative vote of both a majority
of the members of our board of directors then in office and a majority of the voting power of all of issued and outstanding shares of our capital stock entitled to vote thereon. 

Company Preferred Stock and Additional Company Common Stock 

Under our Certificate of Incorporation, our board of directors has the authority to provide by board resolution for the issuance of preferred shares in one or
more series and to fix the terms and conditions of each such series. The authorized shares of preferred stock, as well as authorized but unissued shares of common stock, are available for issuance without further action by our stockholders, unless
stockholder action is required by applicable law or the rules of the New York Stock Exchange or any other stock exchange on which any class or series of our stock may then be listed. 

These provisions give the our board of directors the power to issue preferred stock, or additional shares of common stock, that could, depending on the terms
of the stock, either impede or facilitate the completion of a merger, tender offer or other takeover attempt. For example, issuing new shares might impede a business combination if the terms of those shares include voting rights which enable a
holder to block business combinations; alternatively, issuing new shares might facilitate a business combination if those shares have general voting rights sufficient to cause an applicable percentage vote requirement to be satisfied. 

Delaware Business Combination Statute 
 Under
certain circumstances, Section 203 of the DGCL makes it more difficult for a person who would be an “interested stockholder” to effect various business combinations with a corporation for a three-year period. However our Certificate
of Incorporation currently contains a provision pursuant to which the Company elects not to be governed by Section 203 of the DGCL. 

Limitations on Directors’ Liability and Indemnification 

Pursuant to authority conferred by Section 102 of the DGCL, Article SIXTH of the Company’s Certificate of Incorporation eliminates the personal
liability of the Company’s directors to the Company or its stockholders for monetary damages for breach of fiduciary duty to the fullest extent permitted under the law of the State of Delaware, including the DGCL. Article SIXTH further provides
that any future amendment to or repeal of its terms will not adversely affect any right or protection of any director of the Company with respect to acts or omissions of such director occurring prior to such repeal or amendment. Article SIXTH also
incorporates any future amendments to Delaware law which further eliminate or limit the liability of directors. 
 In accordance with Section 145 of
the DGCL, Article SEVENTH of the Company’s Certificate of Incorporation and certain provisions of the Company’s Bylaws grant the Company’s directors and officers a right to indemnification for all expenses relating to civil, criminal,
administrative or investigative procedures to which they are a party (i) by reason of the fact that they are or were directors or officers of the Company or (ii) by reason of the fact that, while they are or were directors or officers of
the Company, they are or were serving at the request of the Company as directors or officers of another corporation, partnership, joint venture, trust or other enterprise, including service with respect to an employee benefit plan. Section 5 of
Article VI of the Company’s Bylaws further provides for advancement of expenses to such indemnified persons. 
 The Company’s Bylaws authorize the
Company to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Company, or is or was serving at the request of the Company as a 

  
 3 

 
director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, including service with respect to an employee benefit plan, against any
liability asserted against such person and incurred by such person in any such capacity, or arising out of such person’s status as such, whether or not the Company would have the power to indemnify such person against such liability under the
provisions of the Company’s Bylaws. The Company has obtained insurance policies insuring its directors and officers against certain liabilities. 

The Company has entered into Indemnification Agreements (the “Indemnification Agreements”) with its directors and executive officers. One of the
purposes of the Indemnification Agreements is to attempt to specify the extent to which persons entitled to indemnification thereunder (the “Indemnitees”) may receive indemnification. Pursuant to the Indemnification Agreements, an
Indemnitee is entitled to indemnification for claims arising out of or in connection with the service of Indemnitee as a director or officer of the Company or of an affiliate. In the case of an action or proceeding other than an action by or in the
right of the Company, the Indemnification Agreements provide that Indemnitee is entitled to indemnification for claims relating to (i) the fact that Indemnitee is or was an officer or director of the Company or any other entity which Indemnitee
is or was or will be serving at the request of the Company, or (ii) anything done or not done by Indemnitee in any such capacity. In the case of an action by or in the right of the Company, the Indemnification Agreements provide that Indemnitee
is entitled to indemnification for claims relating to (i) the fact that Indemnitee is or was an officer or director of the Company or any affiliate or (ii) anything done or not done in such capacity. The Indemnification Agreements are in
addition to and are not intended to limit any rights of indemnification which are available under the Company’s Certificate of Incorporation or the Company’s Bylaws, or otherwise. In addition to the rights to indemnification specified
therein, the Indemnification Agreements are intended to increase the certainty of receipt by the Indemnitee of the benefits to which he or she is entitled by providing specific procedures relating to indemnification. 

We believe that our Certificate of Incorporation and Bylaws and insurance are necessary to attract and retain qualified persons as directors and officers.

 The limitation of liability and indemnification provisions in our Certificate of Incorporation and Bylaws may discourage stockholders from bringing a
lawsuit against directors for breach of their fiduciary duty. They may also reduce the likelihood of derivative litigation against directors and officers, even though an action, if successful, might benefit us and other stockholders. Furthermore, a
stockholder’s investment may be adversely affected to the extent we pay the costs of settlement and damage awards against directors and officers as required or allowed by these indemnification provisions. 

Forum Selection 
 Our Bylaws provide that, unless the
Company consents in writing to the selection of an alternative forum, a state or federal court located within the State of Delaware will be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the
Company, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Company to the Company or the Company’s stockholders, (iii) any action asserting a claim arising pursuant
to any provision of the Delaware General Corporation Law, or (iv) any action asserting a claim governed by the internal affairs doctrine. 

  
 4EX-10.4

 Exhibit 10.4 

AMENDMENT NO. 2 dated as of November 12, 2019 (this “Amendment”), to the ABL Credit Agreement
dated as of April 3, 2018 (as amended by Amendment No. 1 dated as of May 3, 2018, and as further heretofore amended, supplemented, amended and restated or otherwise modified, the “ABL Credit Agreement”),
among CHS/COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation (the “Borrower”), COMMUNITY HEALTH SYSTEMS, INC., a Delaware corporation (“Parent”), the lenders party thereto (the
“Lenders”) and JPMORGAN CHASE BANK, N.A., as administrative agent (in such capacity, the “Administrative Agent”) and as collateral agent for the Lenders. 

PRELIMINARY STATEMENT 

SECTION 1. Defined Terms. Capitalized terms used but not otherwise defined herein (including the Preliminary Statement hereto)
shall have the meanings assigned thereto in the ABL Credit Agreement. The provisions of Section 1.02 of the ABL Credit Agreement are hereby incorporated by reference herein, mutatis mutandis. This Amendment shall be a “Loan
Document” for all purposes of the ABL Credit Agreement and the other Loan Documents. 
 SECTION 2. Amendments to the ABL Credit
Agreement. Subject to the satisfaction of the conditions set forth in Section 4 hereof, the ABL Credit Agreement is hereby amended as follows, effective as of the Amendment No. 2 Effective Date (as defined below): 

(a) The definition of the term “Term Loan Credit Agreement” in Section 1.01 of the ABL Credit Agreement is hereby amended and
restated in its entirety as follows: 
 “Term Loan Credit Agreement” shall mean the Fourth Amended and Restated
Credit Agreement dated as of March 23, 2018, among, inter alia, Parent, the Borrower, the lenders from time to time party thereto and Credit Suisse AG, Cayman Islands Branch, as administrative agent and as the Term Loan Collateral Agent,
as in effect immediately prior to the repayment in full of all indebtedness outstanding thereunder and the termination of all commitments thereunder. 

(b) Section 2.23 of the ABL Credit Agreement is hereby amended by: 

(i) adding the following to the end of paragraph (a) thereof: “To the extent agreed by the Borrower, the
Administrative Agent and the applicable Issuing Bank and pursuant to procedures acceptable to the Administrative Agent, the Borrower may designate any Letter of Credit (as defined in the Term Loan Credit Agreement) to be a Letter of Credit under
this Agreement. Any such designation shall be subject to the conditions set forth in Section 4.02 and in this 

 
Section 2.23 and upon such designation and the satisfaction of such conditions, any such Letter of Credit (as defined in the Term Loan Credit Agreement) so designated shall be deemed to have
been issued under this Agreement for all purposes.”; and 
 (ii) replacing “$50,000,000” in paragraph
(b) thereof with “$200,000,000”. 
 (c) Schedule 2.01 of the ABL Credit Agreement is hereby amended by replacing the table
titled “L/C Commitments” and inserting the following in lieu thereof: 
 L/C COMMITMENTS* 

 

	*	 on file with the agent 

Each Issuing Bank party hereto agrees, by its execution of this Amendment, to amend its respective L/C Commitment as set forth above. 

SECTION 3. Representations and Warranties. To induce the other parties hereto to enter into this Amendment, each of Parent and the
Borrower hereby represents and warrants to each of the Lenders party hereto, the Administrative Agent, the Issuing Banks and the Collateral Agent that, after giving effect to this Amendment: 

(a) The representations and warranties set forth in Article III of the ABL Credit Agreement and in each other Loan Document are true and
correct in all material respects (or, in the case of representations and warranties qualified by materiality or Material Adverse Effect, in all respects) on and as of the Amendment No. 2 Effective Date with the same effect as though made on and
as of such date, except to the extent such representations and warranties expressly relate to an earlier date, in which case such representations and warranties shall have been true and correct in all material respects (or, in the case of the
representations and warranties qualified by materiality or Material Adverse Effect, in all respects) as of such earlier date. 
 (b) No
Default or Event of Default has occurred and is continuing. 
 (c) None of the Security Documents in effect on the Amendment No. 2
Effective Date will be rendered invalid, non-binding or unenforceable against any Loan Party as a result of this Amendment. The Guarantees created under such Security Documents will continue to guarantee the
Obligations to the same extent as they guaranteed the Obligations immediately prior to the Amendment No. 2 Effective Date. The Liens created under such Security Documents will continue to secure the Obligations, and will continue to be
perfected, in each case, to the same extent as they secured the Obligations or were perfected immediately prior to the Amendment No. 2 Effective Date. 

SECTION 4. Effectiveness. This Amendment shall become effective on and as of the first date (the “Amendment
No. 2 Effective Date”) after which: 

  
 2 

 (a) The Administrative Agent shall have received duly executed and delivered counterparts of
this Amendment that, when taken together, bear the signatures of Parent, the Borrower and the Required Lenders; and 
 (b) All indebtedness
outstanding under the Term Loan Credit Agreement shall have been repaid in full and all commitments thereunder shall have been terminated. 

SECTION 5. Designation of Letters of Credit. Pursuant to Section 2.23 of the ABL Credit Agreement as amended hereby, the
Borrower and the Administrative Agent hereby agree that as of the Amendment No. 2 Effective Date, each of the letters of credit identified hereto on Schedule I shall, from such date, be deemed to have been issued under the ABL Credit Agreement
as contemplated by Section 2.23 thereof as amended hereby. 
 SECTION 6. Miscellaneous. Except as expressly set forth
herein, this Amendment shall not constitute a waiver or amendment of, or otherwise affect the rights and remedies of the Administrative Agent, the Lenders or any other Secured Party under the ABL Credit Agreement or any other Loan Document. From and
after the Amendment No. 2 Effective Date, any reference to the ABL Credit Agreement shall mean the ABL Credit Agreement as modified by this Amendment. This Amendment may be executed in one or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same instrument. Delivery by electronic transmission (e.g., “pdf”) of an executed counterpart of a signature page to this Amendment shall be effective as delivery of an
original executed counterpart of this Amendment. This amendment shall be governed by, and construed in accordance with, the laws of the State of New York. 

[Remainder of page intentionally left blank] 

  
 3 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by
their respective authorized officers as of the date first above written. 
  

					
	CHS/COMMUNITY HEALTH SYSTEMS, INC.,
		
	      By:	 	 /s/ Kevin J. Hammons

		 	Name:	 	Kevin J. Hammons
		 	Title:	 	Senior Vice President, Assistant Chief Financial Officer, Chief Accounting Officer and Treasurer
	
	COMMUNITY HEALTH SYSTEMS, INC.,
		
	      By:	 	 /s/ Kevin J. Hammons

		 	Name:	 	Kevin J. Hammons
		 	Title:	 	Senior Vice President, Assistant Chief Financial Officer, Chief Accounting Officer and Treasurer

 [Signature Page to Amendment No. 2 to the ABL Credit Agreement] 

 
					
	 JPMORGAN CHASE BANK, N.A.,
 as a
Lender, an Issuing Bank and the Administrative Agent and Collateral Agent

		
	By:	 	 /s/ Dawn Lee Lum

		 	Name:	 	Dawn Lee Lum
		 	Title:	 	Executive Director

 [Signature Page to Amendment No. 2 to the ABL Credit Agreement] 

 
					
	 CITIBANK, N.A.,
 as a Lender and an
Issuing Bank

		
	By:	 	 /s/ David L. Smith

		 	Name:	 	David L. Smith
		 	Title:	 	Vice President and Director

 [Signature Page to Amendment No. 2 to the ABL Credit Agreement] 

 
					
	 CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH,

as a Lender and an Issuing Bank

		
	By:	 	 /s/ Judith Smith

		 	Name:	 	Judith Smith
		 	Title:	 	Authorized Signatory
		
	By:	 	 /s/ Lingzi Huang

		 	Name:	 	Lingzi Huang
		 	Title:	 	Authorized Signatory

 [Signature Page to Amendment No. 2 to the ABL Credit Agreement] 

 
			
	 BANK OF AMERICA, N.A.,
 as a Lender
and an Issuing Bank

		
	By:	 	 /s/ Steven L. Hipsman

		 	Name:  Steven L. Hipsman
		 	Title:    Senior Vice President

 [Signature Page to Amendment No. 2 to the ABL Credit Agreement] 

 
			
	 ROYAL BANK OF CANADA,
 as a Lender
and an Issuing Bank

		
	By:	 	 /s/ Jeff Patchell

		 	Name:  Jeff Patchell
		 	Title:    Attorney In Fact

 [Signature Page to Amendment No. 2 to the ABL Credit Agreement] 

 
			
	WELLS FARGO BANK, NATIONAL ASSOCIATION, as a Lender and an Issuing Bank
		
	By:	 	 /s/ Salvatore Tulumello

		 	Name:  Salvatore Tulumello
		 	Title:    Vice President

 [Signature Page to Amendment No. 2 to the ABL Credit Agreement] 

 
					
	 LENDER SIGNATURE PAGE TO THE CHS/COMMUNITY HEALTH SYSTEMS, INC.

ABL CREDIT AGREEMENT

	
	Name of Lender:*
		
	By:	 	      

		 	Name:	 	    
		 	Title:	 	    
	
	For Lenders requiring a second signature line:
		
	By:	 	      

		 	Name:	 	    
		 	Title:	 	    

  

	*	 On file with Agent 

[Signature Page to Amendment No. 2 to the ABL Credit Agreement] 

 SCHEDULE I 
  

	*	 On file with Agent

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00304-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00304-of-00352.parquet"}]]